Best of luck
When next quarter GSK Relenza figures are out, will be the real test of SP resilience. Unless something drastic changes I dont see any light on the horizon.
In fact i see a vastly different current quarter to last year corresponding quarter.
This the the formula BTA will make a market ann on.
Check out the numbers. If the trend continues (Remember TJW )
It's not looking flash re relenza sales.